Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3-4
pubmed:dateCreated
1998-9-8
pubmed:abstractText
Using a variety of expression systems the number of available recombinant ovine cytokines has increased steadily. This has led to the use of ovine cytokines as adjuvants to modulate the immune responses to vaccine antigens, both quantitatively and qualitatively. In addition DNA immunization, now common in mice, is being increasingly used in sheep. This may provide a unique avenue for the use of cytokines as immunomodulators, as it avoids preparing large quantities of biologically active recombinant protein and allows a slow, prolonged release of the cytokine at the same site as the antigen. As detection systems are developed their usefulness and shortcomings become apparent. The combination of cytokine detection, lymphatic cannulation and the in vivo neutralization of cytokines has allowed a greater understanding of the immune response during vaccination and of the interaction between pathogens and the immune system.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0928-4249
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
369-83
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Ovine cytokines and their role in the immune response.
pubmed:affiliation
CRC for Vaccine Technology Unit, CSIRO, Division of Animal Health, Victoria, Australia. Jean-Pierre.Scheerlinck@CSIRO.au
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't